Study Evaluating Intravitreal hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
Public ClinicalTrials.gov record NCT02358889. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Randomized, Double-masked, Multicenter, Active-controlled Study Evaluating Administration of Repeated Intravitreal Doses of hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety, biological activity and pharmacodynamic effect of repeated intravitreal doses of hI-con1 0.3 mg administered as monotherapy and in combination with ranibizumab 0.5 mg compared to ranibizumab 0.5 mg monotherapy in treating patients with choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD).
Study identification
- NCT ID
- NCT02358889
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 88 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2015 (Type not available)
- Primary completion
- Sep 2016 (Actual)
- Completion
- Sep 2016 (Actual)
- Last update posted
- Sep 24, 2020
2015 – 2016
United States locations
- U.S. sites
- 48
- U.S. states
- 21
- U.S. cities
- 47
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Phoenix | Arizona | 85020 | — |
| Not listed | Phoenix | Arizona | 85021 | — |
| Not listed | Arcadia | California | 91007 | — |
| Not listed | Beverly Hills | California | 90211 | — |
| Not listed | Campbell | California | 95008 | — |
| Not listed | Glendale | California | 91203 | — |
| Not listed | Laguna Hills | California | 92653 | — |
| Not listed | Mountain View | California | 94040 | — |
| Not listed | Palm Desert | California | 92260 | — |
| Not listed | Palo Alto | California | 94303 | — |
| Not listed | San Francisco | California | 94109 | — |
| Not listed | Santa Ana | California | 92705 | — |
| Not listed | Golden | Colorado | 80401 | — |
| Not listed | Boynton Beach | Florida | 33426 | — |
| Not listed | Fort Myers | Florida | 33907 | — |
| Not listed | Panama City | Florida | 32405 | — |
| Not listed | Sarasota | Florida | 34233 | — |
| Not listed | Stuart | Florida | 34994 | — |
| Not listed | Winter Haven | Florida | 33907 | — |
| Not listed | Augusta | Georgia | 30909 | — |
| Not listed | Paducah | Kentucky | 42001 | — |
| Not listed | Baltimore | Maryland | 21209 | — |
| Not listed | Boston | Massachusetts | 02111 | — |
| Not listed | Detroit | Michigan | 48072 | — |
| Not listed | Jackson | Michigan | 49202 | — |
| Not listed | Royal Oak | Michigan | 48073 | — |
| Not listed | West Bloomfield | Michigan | 48322 | — |
| Not listed | Minneapolis | Minnesota | 55435 | — |
| Not listed | Las Vegas | Nevada | 89144 | — |
| Not listed | Bloomfield | New Jersey | 07003 | — |
| Not listed | Brooklyn | New York | 11223 | — |
| Not listed | Hauppauge | New York | 11788 | — |
| Not listed | Syracuse | New York | 13224 | — |
| Not listed | Ashland | Oregon | 97520 | — |
| Not listed | Portland | Oregon | 97210 | — |
| Not listed | Huntingdon Valley | Pennsylvania | 19006 | — |
| Not listed | Philadelphia | Pennsylvania | 19107 | — |
| Not listed | West Columbia | South Carolina | 29169 | — |
| Not listed | Kingsport | Tennessee | 37660 | — |
| Not listed | Abilene | Texas | 79606 | — |
| Not listed | Austin | Texas | 78705 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | McAllen | Texas | 78503 | — |
| Not listed | San Antonio | Texas | 78240 | — |
| Not listed | The Woodlands | Texas | 77384 | — |
| Not listed | Salt Lake City | Utah | 84107 | — |
| Not listed | Silverdale | Washington | 98383 | — |
| Not listed | Madison | Wisconsin | 53705 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02358889, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 24, 2020 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02358889 live on ClinicalTrials.gov.